Richard Slayman, 62, underwent the four-hour procedure on March 16 to treat end-stage kidney disease. The pig kidney, provided by Cambridge, Mass.-based eGenesis, contained 69 genomic edits to improve its compatibility with humans.
“This moment — leaving the hospital today with one of the cleanest bills of health I’ve had in a long time — is one I wished would come for many years,” Mr. Slayman said in an April 3 news release shared with Becker’s. “I want to thank anyone who has seen my story and sent well-wishes, especially patients waiting for a kidney transplant. Today marks a new beginning not just for me, but for them, as well.”
The procedure represents a historical milestone in the field of xenotransplantation and could offer a potential solution to the global organ shortage, according to Massachusetts General.
Surgeons at University of Maryland Medical Center in Baltimore previously transplanted genetically-modified pig hearts into two patients, though both died within a few weeks of their procedures.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
